Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
8.97
+0.17 (1.93%)
At close: Aug 13, 2025, 4:00 PM
8.92
-0.05 (-0.56%)
Pre-market: Aug 14, 2025, 8:40 AM EDT
Evolent Health Market Cap
Evolent Health has a market cap or net worth of $1.04 billion as of August 14, 2025. Its market cap has decreased by -61.62% in one year.
Market Cap
1.04B
Enterprise Value
1.74B
1-Year Change
-61.62%
Ranking
Category
Stock Price
$8.97
Market Cap Chart
Since June 5, 2015, Evolent Health's market cap has decreased from $1.05B to $1.04B, a decrease of -1.07%. That is a compound annual growth rate of -0.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 1.05B | -19.61% |
| Dec 31, 2024 | 1.31B | -65.47% |
| Dec 29, 2023 | 3.80B | 33.63% |
| Dec 30, 2022 | 2.84B | 14.85% |
| Dec 31, 2021 | 2.47B | 79.93% |
| Dec 31, 2020 | 1.38B | 79.57% |
| Dec 31, 2019 | 765.70M | -53.32% |
| Dec 31, 2018 | 1.64B | 72.46% |
| Dec 29, 2017 | 951.20M | -5.38% |
| Dec 30, 2016 | 1.01B | 40.70% |
| Dec 31, 2015 | 714.50M | -32.05% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |